Fujian Wanchen Biotechnology Group: Summary table of non-operational funds and other related fund transactions for the first half of 2024 for listed companies.
Fujian Wanchen Biotechnology Group: Legal opinion of Guohao Law Firm (Beijing) on the fourth interim shareholders' meeting of Fujian Wanchen Biological Technology Group Co., Ltd. in 2024.
Fujian Wanchen Biotechnology Group: Announcement of Resolutions of the Fourth Extraordinary Shareholders' Meeting in 2024.
Fujian Wanchen Biotechnology Group: Notice of the company's fourth extraordinary shareholders' meeting in 2024.
Fujian Wanchen Biotechnology Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Fujian Wanchen Biotechnology Group: Legal Opinion of Guohao Law Firm (Beijing) on the 2023 Annual General Meeting of Shareholders of Fujian Wanchen Biotechnology Group Co., Ltd.
Fujian Wanchen Biotechnology Group: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Fujian Wanchen Biotechnology Group: Legal Opinion of Guohao Law Firm (Beijing) on the 2024 Third Extraordinary General Meeting of Shareholders of Fujian Wanchen Biotechnology Group Co., Ltd.
Wanchen Group: Notice on requesting the shareholders' meeting to authorize the board of directors to handle matters relating to issuing shares to specific targets through simplified procedures
Wanchen Group: Salary (Allowance) Performance Plan for the Company's 2024 Directors and Senior Managers
Wanchen Group: Notice on convening the 2023 Annual General Meeting of Shareholders of the Company
Wanchen Group: Summary table on the use of non-operating capital and other related capital transactions in 2023
Wanchen Group: The Company's 2024 Supervisor Remuneration (Allowance) Performance Plan
Wanchen Group: Announcement on the Use of Some Idle Funds Raised and Own Funds for Cash Management
Wanchen Group: 2023 Internal Control Self-Assessment Report
Wanchen Group: 2023 Financial Results Report
Wanchen Group: Announcement on the company's mid-term dividend arrangement for 2024
Wanchen Group: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Wanchen Group: An indicative announcement on the listing and circulation of shares already issued before the initial public offering
Wanchen Group: Announcement on adding a special account to raise capital and signing a quadripartite supervision agreement
No Data